Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
As more pharmaceutical interventions demonstrate efficacy similar to or better than comparable surgical interventions, physician practice patterns will continue to impact the longstanding procedure-based approach to medicine
"The Medicare GLP-1 Bridge program is a significant step forward for people living with obesity who have long faced barriers to access under Medicare," said Joe Nadglowski, President and CEO of the Obesity Action Coalition (OAC)
Research on both medications continues to show promising results
"Anecdotally, health systems have closed hospital-based metabolic bariatric surgery programs due to decreased demand," they noted in the introduction to their study
When calorie intake is reduced, as it often is with GLP-1 medications, protein needs may increase
US$ 26.36
US$ 23.30
US$ 21.70
